1. Home
  2. PEBK vs AVXL Comparison

PEBK vs AVXL Comparison

Compare PEBK & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Peoples Bancorp of North Carolina Inc.

PEBK

Peoples Bancorp of North Carolina Inc.

HOLD

Current Price

$43.14

Market Cap

218.4M

Sector

Finance

ML Signal

HOLD

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

HOLD

Current Price

$2.63

Market Cap

237.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PEBK
AVXL
Founded
1912
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
218.4M
237.2M
IPO Year
2012
2013

Fundamental Metrics

Financial Performance
Metric
PEBK
AVXL
Price
$43.14
$2.63
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$22.00
AVG Volume (30 Days)
34.6K
1.4M
Earning Date
04-20-2026
05-08-2026
Dividend Yield
2.58%
N/A
EPS Growth
21.48
N/A
EPS
0.80
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$54.20
N/A
Revenue Growth
N/A
N/A
52 Week Low
$26.81
$2.41
52 Week High
$45.78
$13.99

Technical Indicators

Market Signals
Indicator
PEBK
AVXL
Relative Strength Index (RSI) 53.95 47.34
Support Level $41.32 $2.62
Resistance Level $45.78 $2.80
Average True Range (ATR) 1.49 0.15
MACD -0.09 0.03
Stochastic Oscillator 37.47 57.69

Price Performance

Historical Comparison
PEBK
AVXL

About PEBK Peoples Bancorp of North Carolina Inc.

Peoples Bancorp of North Carolina Inc is a bank holding company. It is a state-chartered commercial bank serving Lincolnton, Newton, Denver, Catawba, Conover, Maiden, Claremont, Hiddenite, Hickory, Charlotte, Cornelius, Raleigh and Cary, North Carolina. It has a diversified loan portfolio with no foreign loans and few agricultural loans. The company's main source of income is dividends declared and paid by the Bank on its capital stock.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

Share on Social Networks: